N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections

Sponsor: David Moss • ClinicalTrials.gov ID: NCT07610967

Registry updated: 2026-10-08
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The purpose of trial is to determine if daily usage of a photobiomodulation device will decrease the incidence of upper respiratory tract infections (URI) due to COVID, influenza or other viruses.The RD-X10 device is handheld, can be self-administered, and has been shown to be safe in invivo studies.

Interventions

  • RD-X19 (Device)
    * Subject will be given the RD-X19 device and shown how to use the device * Subjects will be instructed to use the device for 5 minutes every other day * Subject will be given "Instructions for Treatment" handout
  • RD-X19 Sham (Device)
    * Subject will be given the sham RD-X19 device and shown how to use the device * Subjects will be instructed to use the sham device for 5 minutes every other day * Subject will be given "Instructions for Treatment" handout

Eligibility criteria

Inclusion Criteria: * Active Duty and DoD Beneficiaries (i.e. former military, spouse, dependent child) aged 18 years and older who work in the Mike O'Callaghan Military Medical Center at Nellis Air Force Base. Exclusion Criteria: * Unable to comfortably insert RD-X19 into the mouth and keep in place for 5 minutes * Plans for head, neck or mouth surgery during the study period * Plans for major dental procedures (ie implants, wisdom teeth extraction etc) during the study

Conditions

COVID-19 Respiratory Infection Influenza

Locations

  • Mike O'Callaghan Military Medical Center — Nellis Air Force Base, Nevada, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record